InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595
$22.35 +0.63% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $22.35 −20.26% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 24 Jul 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Revenue31.1Operating income−22.2Net income−21.7Fiscal year 2020Revenue17.8 −42.7%Operating income−65.0Net income−43.2Fiscal year 2021Revenue29.8 +66.9%Operating income−117.9Net income−117.2EPS, diluted−2.73Fiscal year 2022Revenue38.6 +29.8%Operating income−183.9Net income−180.4EPS, diluted−3.71Fiscal year 2023Revenue77.0 +99.3%Operating income−155.1Net income−143.9EPS, diluted−2.65Fiscal year 2024Revenue54.5 −29.1%Operating income−213.0Net income−193.6EPS, diluted−2.88Fiscal year 2025Revenue84.0 +54.0%Operating income−285.7Net income−264.5EPS, diluted−3.05
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 31.1 17.8 29.8 38.6 77.0 54.5 84.0
Growth −42.7% +66.9% +29.8% +99.3% −29.1% +54.0%
Operating income −22.2 −65.0 −117.9 −183.9 −155.1 −213.0 −285.7
Net income −21.7 −43.2 −117.2 −180.4 −143.9 −193.6 −264.5
Growth
EPS, diluted n/a n/a −2.73 −3.71 −2.65 −2.88 −3.05
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Operating margin−71.5%Net margin−69.7%Free cash flow margin−3.4%Fiscal year 2020Operating margin−364.7%Net margin−242.7%Free cash flow margin−26.0%Fiscal year 2021Operating margin−396.3%Net margin−393.9%Free cash flow margin−302.6%Fiscal year 2022Operating margin−476.0%Net margin−466.9%Free cash flow margin−445.4%Fiscal year 2023Operating margin−201.4%Net margin−187.0%Free cash flow margin−116.6%Fiscal year 2024Operating margin−390.5%Net margin−354.9%Free cash flow margin−333.4%Fiscal year 2025Operating margin−340.2%Net margin−314.9%Free cash flow margin−313.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −71.5% −364.7% −396.3% −476.0% −201.4% −390.5% −340.2%
Net margin −69.7% −242.7% −393.9% −466.9% −187.0% −354.9% −314.9%
Free cash flow margin −3.4% −26.0% −302.6% −445.4% −116.6% −333.4% −313.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow0.6Capital expenditure−1.7Free cash flow−1.1Fiscal year 2020Operating cash flow−0.1Capital expenditure−4.6Free cash flow−4.6Fiscal year 2021Operating cash flow−84.4Capital expenditure−5.7Free cash flow−90.0Fiscal year 2022Operating cash flow−159.8Capital expenditure−12.2Free cash flow−172.1Fiscal year 2023Operating cash flow−81.4Capital expenditure−8.4Free cash flow−89.8Fiscal year 2024Operating cash flow−172.6Capital expenditure−9.3Free cash flow−181.9Fiscal year 2025Operating cash flow−249.5Capital expenditure−14.0Free cash flow−263.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.6 −0.1 −84.4 −159.8 −81.4 −172.6 −249.5
Capital expenditure −1.7 −4.6 −5.7 −12.2 −8.4 −9.3 −14.0
Free cash flow −1.1 −4.6 −90.0 −172.1 −89.8 −181.9 −263.5
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2019Cash34.8Shareholders’ equity−57.7Fiscal year 2020Cash119.4Shareholders’ equity290.3Fiscal year 2021Cash80.5Shareholders’ equity342.3Fiscal year 2022Cash64.5Shareholders’ equity303.7Fiscal year 2023Cash54.6Shareholders’ equity200.5Fiscal year 2024Cash110.0Shareholders’ equity527.0Fiscal year 2025Cash247.0Shareholders’ equity538.7
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 34.8 119.4 80.5 64.5 54.6 110.0 247.0
Shareholders’ equity −57.7 290.3 342.3 303.7 200.5 527.0 538.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending November, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 30 Nov 2019 FY2020 30 Nov 2020 FY2021 30 Nov 2021 FY2022 30 Nov 2022 FY2023 30 Nov 2023 FY2024 30 Nov 2024 FY2025 30 Nov 2025
Revenue and profit
31.1 17.8 29.8 38.6 77.0 54.5 84.0
Growth −42.7% +66.9% +29.8% +99.3% −29.1% +54.0%
45.0 66.5 116.4 184.5 189.1 221.6 316.9
8.3 16.3 31.2 38.0 42.9 45.9 52.7
−22.2 −65.0 −117.9 −183.9 −155.1 −213.0 −285.7
Growth
−21.5 −63.8 −117.1 −180.4 −143.9 −193.3 −263.7
0.2 −20.5 0.1 0.0 0.0 0.3 0.8
−21.7 −43.2 −117.2 −180.4 −143.9 −193.6 −264.5
Growth
Per share
n/a n/a −2.73 −3.71 −2.65 −2.88 −3.05
n/a n/a −2.73 −3.71 −2.65 −2.88 −3.05
Growth
n/a n/a 42.9 48.6 54.3 67.1 86.7
n/a n/a 42.9 48.6 54.3 67.1 86.7
Growth +13.3% +11.8% +23.5% +29.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 36.3% a year over five years.
  • Operating margin is up 24.5 points on five years ago, at -340.2%.
  • A net loss in 7 of 7 years on file.